EUVIMEDEUVIMED entdecken
Open Access

Iterative Development of a Clinical Decision Support Tool to Enhance Naloxone Coprescribing

Richard Wu, Emily Foster, Qiyao Zhang, Tim Eynatian, Rebecca Mishuris, Nicholas Cordella

Applied Clinical Informatics · 01.01.2025 · 16 (01) · 215-222

DOI: 10.1055/a-2447-8463 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Applied Clinical Informatics, erschienen am 01.01.2025. Verfasst von Richard Wu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Chobanian and Avedisian School of Medicine, Boston University, Boston, Massachusetts, United States. Hauptthemen laut MEDLINE: Naloxone, Decision Support Systems, Clinical, Drug Prescriptions. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Opioid overdoses have contributed significantly to mortality in the United States. Despite long-standing recommendations from the Centers for Disease Control and Prevention to coprescribe naloxone for patients receiving opioids who are at high risk of overdose, compliance with these guidelines has remained low.

Objectives

The objective of this study was to develop and evaluate a hospital-wide electronic health record (EHR)-based clinical decision support (CDS) tool designed to promote naloxone coprescription for high-risk opioids.

Methods

We employed an iterative approach to develop a point-of-order, interruptive EHR alert as the primary intervention and assessed naloxone prescription rates, EHR efficiency metrics, and barriers to adoption. Data were obtained from our EHR's clinical data warehouse and analyzed using statistical process control with odds ratios calculated to quantify statistically significant differences in prescribing rates during the intervention periods.

Results

The initial implementation phase of the intervention, spanning from April 2019 to May 2022, yielded a nearly 3-fold increase in the proportion of high-risk patients receiving naloxone, rising from 13.4% (95% confidence interval [CI], 12.9–13.8%) to 36.4% (95% CI, 35.2–37.5%; p = 10−38). Enhancements to the CDS design and logic during the subsequent iteration's study period, June 2022 and December 2023, reduced the number of CDS triggers by more than 30-fold while simultaneously driving an additional increase in naloxone receipt to 42.7% (95% CI, 40.6–44.8%; p = 2 × 10−5). The efficiency of the CDS demonstrated marked improvement, with prescribers accepting the naloxone coprescription recommendation provided by the CDS in 41.1% of the encounters in version 2, compared with 6.2% in version 1 (p = 6 × 10−9).

Conclusion

This study offers a sustainable and scalable model to address low rates of naloxone coprescription and may also be used to target other opportunities for improving guideline-concordant prescribing practices.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NaloxoneDecision Support Systems, ClinicalDrug PrescriptionsHumansElectronic Health Records

Substanzen

Naloxone

Autor:innen und Institutionen

  • Chobanian and Avedisian School of Medicine, Boston University, Boston, Massachusetts, United States.
  • Department of IT and Analytics, Boston Medical Center, Boston, Massachusetts, United States.
  • Department of General Internal Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States.
  • Digital, Mass General Brigham, Somerville, Massachusetts, United States.
  • Department of Medicine, Chobanian and Avedisian School of Medicine, Boston University, Boston, Massachusetts, United States.
  • Department of Quality and Patient Safety, Boston Medical Center, Boston, Massachusetts, United States.

Zitieren

APA

Wu, R., Foster, E., Zhang, Q., Eynatian, T., Mishuris, R., & Cordella, N. (2025). Iterative Development of a Clinical Decision Support Tool to Enhance Naloxone Coprescribing. Applied Clinical Informatics, 16(01), 215-222. https://doi.org/10.1055/a-2447-8463

Vancouver

Wu R, Foster E, Zhang Q, Eynatian T, Mishuris R, Cordella N. Iterative Development of a Clinical Decision Support Tool to Enhance Naloxone Coprescribing. Applied Clinical Informatics. 2025;16(01):215-222. doi:10.1055/a-2447-8463

BibTeX
@article{Wu2025,
  author = {Wu, Richard and Foster, Emily and Zhang, Qiyao and Eynatian, Tim and Mishuris, Rebecca and Cordella, Nicholas},
  title = {Iterative Development of a Clinical Decision Support Tool to Enhance Naloxone Coprescribing},
  journal = {Applied Clinical Informatics},
  year = {2025},
  volume = {16},
  number = {01},
  pages = {215--222},
  doi = {10.1055/a-2447-8463}
}
Kostenlos starten →